Morgan Stanley’s Unity Biotechnology UBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$23.3K Buy
60,556
+17,200
+40% +$6.61K ﹤0.01% 6607
2025
Q1
$45.1K Sell
43,356
-36,685
-46% -$38.2K ﹤0.01% 6304
2024
Q4
$78.2K Buy
80,041
+35,350
+79% +$34.5K ﹤0.01% 6148
2024
Q3
$65.7K Sell
44,691
-8,517
-16% -$12.5K ﹤0.01% 6137
2024
Q2
$71.8K Buy
53,208
+15,798
+42% +$21.3K ﹤0.01% 6069
2024
Q1
$61.4K Sell
37,410
-36,110
-49% -$59.2K ﹤0.01% 6139
2023
Q4
$142K Buy
73,520
+42,874
+140% +$82.7K ﹤0.01% 6056
2023
Q3
$73.6K Sell
30,646
-15,768
-34% -$37.8K ﹤0.01% 6011
2023
Q2
$118K Sell
46,414
-1,037
-2% -$2.64K ﹤0.01% 5873
2023
Q1
$77.3K Buy
47,451
+2,397
+5% +$3.91K ﹤0.01% 6108
2022
Q4
$123K Buy
45,054
+26,846
+147% +$73.6K ﹤0.01% 5888
2022
Q3
$72K Buy
18,208
+3,469
+24% +$13.7K ﹤0.01% 6238
2022
Q2
$82K Buy
14,739
+325
+2% +$1.81K ﹤0.01% 6380
2022
Q1
$161K Sell
14,414
-2,917
-17% -$32.6K ﹤0.01% 6039
2021
Q4
$253K Sell
17,331
-32,619
-65% -$476K ﹤0.01% 5938
2021
Q3
$1.5M Sell
49,950
-41,507
-45% -$1.25M ﹤0.01% 4788
2021
Q2
$4.24M Buy
91,457
+74,683
+445% +$3.47M ﹤0.01% 3953
2021
Q1
$1.01M Sell
16,774
-22,891
-58% -$1.37M ﹤0.01% 4728
2020
Q4
$2.08M Buy
39,665
+28,491
+255% +$1.49M ﹤0.01% 4122
2020
Q3
$387K Sell
11,174
-6,486
-37% -$225K ﹤0.01% 4766
2020
Q2
$1.53M Buy
17,660
+11,616
+192% +$1.01M ﹤0.01% 3833
2020
Q1
$351K Sell
6,044
-15,993
-73% -$929K ﹤0.01% 4579
2019
Q4
$1.59M Buy
22,037
+14,566
+195% +$1.05M ﹤0.01% 4213
2019
Q3
$455K Sell
7,471
-3,791
-34% -$231K ﹤0.01% 4726
2019
Q2
$1.07M Sell
11,262
-33,666
-75% -$3.2M ﹤0.01% 4178
2019
Q1
$3.64M Buy
44,928
+37,255
+486% +$3.02M ﹤0.01% 3015
2018
Q4
$1.25M Sell
7,673
-4,775
-38% -$777K ﹤0.01% 4119
2018
Q3
$2.03M Buy
12,448
+7,984
+179% +$1.3M ﹤0.01% 3988
2018
Q2
$672K Buy
+4,464
New +$672K ﹤0.01% 4895